Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial

Ivo W. Tremont-Lukats, Bin S. Teh

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S589-S591
JournalTranslational Cancer Research
Volume8
DOIs
StatePublished - Dec 1 2019

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this